MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$52K
Net Income
-$5,732K
Net Profit Margin
-11023.08%
EPS
-$2.83
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2024-09-30
Revenue from contract with customer, excluding assessed tax
52
Research and development expense
3,165
General and administrative expense
1,439
Costs and expenses
4,604
Operating income (loss)
-4,552
Loss on settlement of warrants
-1,106
Change in fair value of warrant liabilities
71
Other nonoperating income (expense)
-3
Income (loss) from continuing operations before income taxes, noncontrolling interest
-5,732
Net loss attributable to vaccinex, inc. common stockholders
-5,732
Basic EPS
-2.83
Diluted EPS
-2.83
Basic Average Shares
2,026,920
Diluted Average Shares
2,026,920
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
attributable to vaccinex,...
-$5,732K
Income (loss) from
continuing operations...
-$5,732K
Operating income (loss)
-$4,552K
Loss on settlement of
warrants
-$1,106K
Change in fair value of
warrant liabilities
$71K
Other nonoperating
income (expense)
-$3K
Revenue from contract
with customer,...
$52K
Costs and expenses
$4,604K
Research and development
expense
$3,165K
General and
administrative expense
$1,439K
Buy us a coffee
VACCINEX, INC. (VCNX)
VACCINEX, INC. (VCNX)